Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 129.6 CHF 0.62%
Market Cap: 2.6B CHF

Wall Street
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 155.45 CHF with a low forecast of 143.42 CHF and a high forecast of 168 CHF.

Lowest
Price Target
143.42 CHF
11% Upside
Average
Price Target
155.45 CHF
20% Upside
Highest
Price Target
168 CHF
30% Upside
Medacta Group SA Competitors:
Price Targets
688301
iRay Technology Co Ltd
16% Upside
BDX
Becton Dickinson and Co
35% Upside
EKF
EKF Diagnostics Holdings PLC
66% Upside
041830
InBody Co Ltd
50% Upside
DXCM
Dexcom Inc
46% Upside
LUCD
Lucid Diagnostics Inc
188% Upside
STMN
Straumann Holding AG
35% Upside
300003
Lepu Medical Technology Beijing Co Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 16%.

13%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's operating income is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOVE's stock price target?
Price Target
155.45 CHF

According to Wall Street analysts, the average 1-year price target for MOVE is 155.45 CHF with a low forecast of 143.42 CHF and a high forecast of 168 CHF.

What is Medacta Group SA's Revenue forecast?
Projected CAGR
16%

For the last 7 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 16%.

What is Medacta Group SA's Operating Income forecast?
Projected CAGR
15%

For the last 7 years the compound annual growth rate for Medacta Group SA's operating income is 10%. The projected CAGR for the next 3 years is 15%.

What is Medacta Group SA's Net Income forecast?
Projected CAGR
17%

For the last 7 years the compound annual growth rate for Medacta Group SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

Back to Top